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Abstract 
 
Curcuma (Curcuma xanthorriza Roxb.) and Awar-awar ((Ficus septica Burm.f.) are well known 
to have anticancer potential especially for breast cancer with low toxicity. This study aims to 
examine the potential effect of the combination of Curcuma ethanolic extracts (CEE) and awar-
awar leaves ethanolic extract (AEE) to increase the efficacy of cisplatin toward T47D breast cancer 
cells. The combination activity was done using 3 series of concentration, 1/3; 1/6 and 1/12 of IC50, 
to determine the combination index (CI) of cisplatin, CEE and AEE under MTT assay. The result 
showed that the combination of 2.5 µM, 5 µg/mL, 1 µg/mL concentrations of  cisplatin, CEE and 
AEE respectively result in synergistic effect with CI values less than 1. The treatment exhibited the 
cell accumulation in S phase (27.7%) against T47D breast cancer cells confirmed through cell cycle 
examination by flow cytometry. These results provided the evidence that the CEE and the AEE can 
be developed as co-chemotherapeutic agents combined with cisplatin to improve the effectiveness 
of breast cancer treatment. 
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INTRODUCTION 
 
Breast cancer generally affects women 
(Siegel, et al., 2014), with an estimated 23% of the 
total cancer cases and 14% death (Jemal, et al., 
2011). Breast cancers occur in Asian women per 
100,000, and Indonesia is the first position with 
25,208 cases (IARC, 2013). To date, cisplatin is still 
being first line chemotherapeutic agent (Dhar, et al., 
2011). However, cisplatin remains causing side 
effects, such as neurotoxicity, nephrotoxicity and 
bone marrow suppression (Milosavlievic, et al., 
2010). The other case found that in the continuous 
use of cisplatin causes resistance through changes in 
the cellular uptake, efflux of drug, inhibition of 
apoptosis and increased DNA repair (Florea and 
Busselberg, 2011). In this case, we should consider 
to maintain the dose of cisplatin. 
Combination chemotherapy is common 
application to cure cancer for more effective 
eradication (Zhao, et al., 2004). Currently, the use of 
herbal medicine as the complementary cancer 
therapy is prefer chosen one due to its safe and 
affordable. The use of herbal medicinal as 
combinatorial chemotherapy is expected to reduce 
the dose of chemotherapeutic agents.  
Curcuma (Curcuma xanthorriza Roxb) as the 
herbal medicine of Indonesia is known to contain 
curcumin that have anticancer activity through 
inhibition of cell proliferation and angiogenesis as 
well as inhibition of NF-κB activation (Foo and 
Nolan, 1999). Meanwhile, fenantroindolisidin 
alkaloid that present in awar-awar (Ficus septica 
Burm. F.) exhibits cytotoxic activity on HCT-8, 
NUGC, and Hone-1 cells (Damu, et al., 2009). Sekti, 
et.al. (2010) reported that ethanolic extract of awar-
awar performed cytotoxic activity suspected to 
induce apoptosis through apoptosis induction against 
MCF-7 cells.  
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Based on these studies, curcuma extract and awar-
awar leaves extract are potential for co-
chemoteraphy in the treatment of breast cancer. This 
study was conducted to examine the synergistic 
effect the combination of curcuma  ethanolic extract 
(CEE) and awar-awar  leaves ethanolic extract 
(AEE) with cisplatin through induction of apoptosis 
and cell cycle modulation on T47D breast cancer 
cells. 
 
MATERIAL AND METHOD 
 
Extract preparation and cell culture 
Curcuma and Awar-awar leaves were 
collected from Balai Besar Pusat Penelitian Tanaman 
Obat dan Obat Tradisional (B2P2TOOT), 
Tawangmangu, Indonesia. The dried powder of the 
samples were macerated using ethanol 70%. T47D 
breast cancer cells were obtained from Prof. 
Kawaichi (NAIST, Japan) were grown in high 
glucose DMEM culture medium containing Fetal 
Bovine Serum (FBS) 10% (v/v), 150 U/mL 
penicillin-150 μg/mL streptomycin (v/v) and 
Fungizone 1.25  μg/mL (Gibco), 0.25% trypsin-
EDTA. 
 
MTT assay 
T47D cells were grown in 96 well plate 
(8x10
3
/well)  and incubated for 24 hours in 5% CO2 
incubator. Before treatment, the media was discarded 
then washed using 1x PBS (100 µl/well). Cells were 
treated with AEE, CEE and cisplatin for 24 hours in 
5% CO2 incubator. MTT reagent (0.5 mg/mL) was 
added as much 100 µL/well then incubated for 3 
hours at 37°C. Stopper solution (SDS 10% in 0.01N 
HCl) was added to stopped reaction and incubated 
overnight at room temperature. The absorbance was 
measured by using ELISA reader at λ 595 nm. 
 
Flowcytometry 
Cells (5 x 10
5
 cells/wells) were grown in 6-
well plate then incubated for 24 hours and treated 
with CEE, AEE, and  cisplatin (WAKO), and 
combination of them. For cell cycle analysis, the 
trypsinized adherent cells were collected and 
detected by adding flow cytometry reagent 
(PI+RNase+Triton-X) then incubated for 10 
minutes. The apoptotic cells were detected by using 
FLOUS-Annexin V Apoptosis Detection Kit. The 
cell suspension was transferred into a flow cytometer 
tube and cell cycle profiles were read by using flow 
cytometry FACS-Calibur. Data were analyzed with 
Flowing software to see the distribution of cells in 
each phase of the cell cycle.  
 
Statistical Analysis 
Cell viability was analyzed statistically by 
using one way ANOVA and Tukey HSD test. 
Statistical significance was placed at p<0.05. 
 
RESULTS 
Cytotoxic effects of the combination of the 
AEE, CEE and Cisplatin in T47D Cells  
The results from MTT assay showed that 
AEE and CEE performed cytotoxic activity against 
T47D with the IC50 values of 7±0.65 µg/mL and 
29.3±1.76 µg/mL respectively. According to Ueda, 
et al., 2002, these results exhibit potential strong 
cytotoxic activity which are smaller than 100 µg/mL. 
Whereas IC50 value of cisplatin is 14.7 ± 0.52 µm. 
For further experiment to examine the combination 
effect, we used concentrations of each agent at 1/3, 
1/6, and 1/12 of IC50 values. The results showed 
changes in cell morphology and cell density. This 
cmbinatin treatment also decrease cell viability 
significantly compared with single treatment of 
cisplatin (p<0.05).  
2.5 μM cisplatin combination treatment, 1 
mg/mL AEE and 5 mg/mL T47D able to reduce cell 
viability by 52.69% (Fig. 1) compared with control 
cells that had been incubated for 24 hours and the CI 
(combination value) was 0.58 (Table 1). These 
results show the combination AEE and CEE can be 
used as cochemotherapy agents to lower the dose of 
cisplatin in the treatment of breast cancer.  
 
 
 
 
 
 
 
Hidayati, et al., 2017 
Indones. J. Cancer Chemoprevent., 8(3), 114-118  
 
116 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. The effect of combination treatment of AEE, CEE and Cisplatin on T47D cell growth. Cells of 8000 
cells/wells in 96-well plates, incubated for 24 hours in DMEM Hi-glucose medium without or with CEE. The 
observations were performed under an inverted microscope with 100x magnification. (a) Cell control; (b) 
Combination of 1/12 IC50; (c) Combination of 1/6 IC50; (d) Combination of 1/3 IC50. The morphology of T47D cells 
that live with arrows (           ) and cells undergoing morphological changes with broken arrows (           ). The 
combined CI values of AEE, CEE and cisplatin showed a synergistic effect (CI <1). 
 
 
Table 1.  Combination Index (CI) value cisplatin with CEE and AEE in T47D cells 
Ratio of  Concenration Cell viability (%) CI 
1/12 IC50 59,98 0,49 
1/6 IC50 47,31 0,53 
1/3 IC50 40,26 0,76 
 
 
Combination AEE, CEE and Cisplatin 
Modulate Cell Cycle in T47D Cells 
The results showed that the AEE causes 
accumulation in S phase, whereas the CEE 
accumulation in S phase and G2/M. Cisplatin 
accumulation in S phase, and combination AEE, 
CEE and cisplatin causes an accumulation    of    
cells    in   S    phase  when  
 
 
compared with control cells. In the combination 
treatment of the percentage distribution of the cell 
cycle at S phase by 27.7 % greater than the single 
cisplatin by 10.35 %. Accumulation of cells in S 
phase due to a combination of increased compared to 
cisplatin. Cell accumulation is possible due to cell 
cycle arrest in the phase . 
 
 
 
Figure 2. Detection of cell cycle distribution using flow cytometry. 5x105 cells were grown in 6 well plates and 
incubated 24 hours in high glucose DMEM medium without or with treatment. Flow cytometry detection using PI 
reagent against T47D cells after AEE treatment 1μg/ml, CEE 5μg/ml.  
  
(a) (b) 
(c) (d) 
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Combination AEE, CEE and Cisplatin has not 
been able to Death Cell Apoptosis in Cells 
T47D 
Analysis of the percentage of cell death 
after treatment CEE, AEE, cisplatin and their 
combination shows untreated cells showed the 
percentage of cell life by 96.58% and amounted to 
3.43% cell death. Cells that have a single treatment 
with the AEE shows cell death of 3.51%; CEE 
showed treatment with cell death by 4.60%; cisplatin 
treatment showed cell death at 6.59%; while the 
third combination treatment (AEE, CEE and 
cisplatin) showed 11.85% cell death. It shows that 
the percentage of cell death AEE, CEE and cisplatin 
increased after the combination of the three. The 
third combination is able to increase cell death 
compared to single-agent cisplatin chemotherapy 
(2.5 m). Combination AEE, CEE and cisplatin can 
increase apoptosis by 5.26% compared with cisplatin 
single (Fig. 3).   
 
DISCUSSION 
 
Test compounds in the AEE and CEE by TLC 
shows alkaloid contained in the AEE and curcumin 
in CEE. In the CEE are curcumin at 
11.586±0.4371% in the 10 mg of extract, to can be 
concluded that ethanolic extract contain pf active 
compound. The results showed a combination of the 
AEE (1 ug/mL), CEE (5 ug/mL) and cisplatin (2.5 
m) decrease cell viability by 39.32% against 
cisplatin (2.5 m). Combination exhibit CI values <1 
that is equal to 0.58, so the effect is synergistic.  
Results of the study showed cell cycle 
modulating a single treatment with the AEE on 
T47D breast cancer cells led to accumulation in S 
phase (27.7%) compared to 10.35% of control cells. 
In the CEE shows the result that the accumulation of 
cells occurs in G2/M phase amounting to 23.28%. 
CEE has been shown to contain compounds 
curcumin. curcumin is able to induce changes in cell 
cycle in cancer HT29 and Widr at G2/M phase (Kim, 
et al., 2005). Cisplatin showed modulating cell cycle 
at S phase by 24.66%. This study is in line with 
previous research which reported that cisplatin-
induced S phase arrest in cell XP30RO where is 
associated with activity in reducing the expression of 
cyclin E and cyclin B (Cruet-Hennequart, et al., 
2009). The treatment combination increases the 
number of cells that accumulate in S phase (27.7%) 
were previously raised by cisplatin (12.45%).  
The combination of the presentation showed 
apoptosis of 10.54%. AEE single treatment induced 
apoptosis by 3.01%, CEE induces apoptosis of 
3.77% and cisplatin showed apoptosis of 5.74%. 
Combination showed apoptosis by 4.8% compared 
to cisplatin alone, combination can increased 
induction of apoptosis. 
  
Figure 3.  Effects of apoptotic induction after AEE, CEE, Cisplatin and combination of all three. Cells were grown 
with density 5x105 density in 6-well plates and incubated 24-hour selem in DMEM Hi-glucose medium without or 
with treatment. Detection of flow cytometry against cell death using Annexin V FLUOS on breast cancer cells T47D 
after treatment of 1 μg/mL AEE, 5 μg/mL CEE, 2.5 μM Cisplatin and a combination of all three. Quadrant R1 shows 
living cells, R2: early apoptosis, R3: late apoptosis, R4: necrosis. 
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CONCLUSION 
 
The conclusion of this research has been done 
that extract awar-awar and ginger extract has the 
potential to  improve the T47D cancer cell sensitivity 
to cisplatin in vitro. Combination AEE, CEE and 
cisplatin have synergistic effects in giving cytotoxic 
effects on breast cancer cells by mechanisms of 
apoptosis induction and cell cycle pathways. Futher 
molecular target detection to investigate its cellular 
pathway needs to be conducted. 
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